DE3884529D1 - Leader-anteile zur produktion von rekombinanten proteinen. - Google Patents

Leader-anteile zur produktion von rekombinanten proteinen.

Info

Publication number
DE3884529D1
DE3884529D1 DE88902750T DE3884529T DE3884529D1 DE 3884529 D1 DE3884529 D1 DE 3884529D1 DE 88902750 T DE88902750 T DE 88902750T DE 3884529 T DE3884529 T DE 3884529T DE 3884529 D1 DE3884529 D1 DE 3884529D1
Authority
DE
Germany
Prior art keywords
production
recombinant proteins
leader
shares
leader shares
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE88902750T
Other languages
English (en)
Other versions
DE3884529T2 (de
Inventor
Peter Keck
Charles Cohen
James Huston
Richard Ridge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Creative Biomolecules Inc
Original Assignee
Creative Biomolecules Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Creative Biomolecules Inc filed Critical Creative Biomolecules Inc
Application granted granted Critical
Publication of DE3884529D1 publication Critical patent/DE3884529D1/de
Publication of DE3884529T2 publication Critical patent/DE3884529T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE88902750T 1987-03-20 1988-03-04 Leader-anteile zur produktion von rekombinanten proteinen. Expired - Fee Related DE3884529T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2850087A 1987-03-20 1987-03-20
PCT/US1988/000729 WO1988007086A1 (en) 1987-03-20 1988-03-04 Leader sequences for the production of recombinant proteins

Publications (2)

Publication Number Publication Date
DE3884529D1 true DE3884529D1 (de) 1993-11-04
DE3884529T2 DE3884529T2 (de) 1994-04-28

Family

ID=21843794

Family Applications (1)

Application Number Title Priority Date Filing Date
DE88902750T Expired - Fee Related DE3884529T2 (de) 1987-03-20 1988-03-04 Leader-anteile zur produktion von rekombinanten proteinen.

Country Status (6)

Country Link
EP (1) EP0305481B1 (de)
JP (1) JP2535066B2 (de)
AU (1) AU601273B2 (de)
CA (1) CA1334943C (de)
DE (1) DE3884529T2 (de)
WO (1) WO1988007086A1 (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260203A (en) * 1986-09-02 1993-11-09 Enzon, Inc. Single polypeptide chain binding molecules
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5869620A (en) * 1986-09-02 1999-02-09 Enzon, Inc. Multivalent antigen-binding proteins
US6025165A (en) * 1991-11-25 2000-02-15 Enzon, Inc. Methods for producing multivalent antigen-binding proteins
EP1170300A1 (de) * 1992-07-13 2002-01-09 Bionebraska, Inc. Verfahren zur Modifizierung rekombinanter Polypeptide
US5656456A (en) * 1992-07-13 1997-08-12 Bionebraska, Inc. Chemical method for selective modification of the N- and/or C-terminal amino acid α-carbon reactive group of a recombinant polypeptide or a portion thereof
WO1994012520A1 (en) * 1992-11-20 1994-06-09 Enzon, Inc. Linker for linked fusion polypeptides
DE4336810A1 (de) * 1993-10-28 1995-05-18 Basf Ag Verfahren zur rekombinanten Herstellung von Proteinen in Hefe
AU4415796A (en) * 1994-12-07 1996-06-26 Bionebraska, Inc. Production of c-terminal amidated peptides from recombinant protein constructs
WO1996017942A1 (en) * 1994-12-07 1996-06-13 Bionebraska, Inc. Production of peptides using recombinant fusion protein constructs
EP0963435B1 (de) 1997-01-08 2008-05-28 Invitrogen Corporation Verfahren zur herstellung von proteinen
KR100620554B1 (ko) 2004-06-05 2006-09-06 한국생명공학연구원 Ｔａｇ-72에 대한 인간화 항체
WO2008042495A2 (en) 2006-07-21 2008-04-10 Life Technologies Corporation Sharply resolving labeled protein molecular weight standards
US7678883B2 (en) * 2007-07-25 2010-03-16 E.I. Du Pont De Nemours And Company Solubility tags for the expression and purification of bioactive peptides
KR101338517B1 (ko) 2011-04-18 2013-12-10 연세대학교 산학협력단 인간 간-카르복실에스터라제 １을 특이적으로 인식하는 단일클론 항체, 상기 항체를 생산하는 하이브리도마 세포주 및 이의 용도
US9115182B2 (en) 2011-06-21 2015-08-25 E I Du Pont De Nemours And Company Cysteine cross-linked structural peptides
CN104812773B (zh) 2012-07-20 2018-04-06 庆熙大学校产学协力团 表位标记用抗体、杂交瘤细胞株以及其用途
CN105636976A (zh) 2012-07-20 2016-06-01 庆熙大学校产学协力团 新型肽标签以及其用途
KR101453462B1 (ko) 2013-05-16 2014-10-23 앱클론(주) Her2에 특이적으로 결합하는 항체
KR101605421B1 (ko) 2014-03-05 2016-03-23 국립암센터 B 세포 림프종 세포를 특이적으로 인지하는 단일클론항체 및 이의 용도
EP3783031B1 (de) 2014-12-03 2023-08-02 Aimed Bio Inc. Antikörper gegen neuropilin 1 und verwendung davon
KR102462811B1 (ko) 2015-04-27 2022-11-04 에이비온 주식회사 항체에 덴드론이 접합된 면역접합체 및 이의 용도
KR101896882B1 (ko) 2015-11-30 2018-09-11 앱클론(주) Vegfr2에 특이적으로 결합하는 항체
KR101887977B1 (ko) 2016-02-15 2018-08-14 사회복지법인 삼성생명공익재단 EGFRvIII (Epidermal Growth Factor Receptor Variant III)에 대한 항체 및 이의 용도
JP2019520086A (ja) 2016-05-27 2019-07-18 オラム・セラピューティクス・インコーポレイテッド 細胞質浸透抗体およびその用途
AU2017273169B2 (en) 2016-06-03 2020-07-30 Aimed Bio Inc. Method for screening antibody using patient-derived tumor spheroids
WO2017209553A2 (ko) 2016-06-03 2017-12-07 사회복지법인 삼성생명공익재단 환자 유래 세포를 이용한 항체 스크리닝 방법
WO2017209554A2 (ko) 2016-06-03 2017-12-07 사회복지법인 삼성생명공익재단 항-nrp1 항체 스크리닝 방법
KR101993893B1 (ko) 2016-06-03 2019-07-01 사회복지법인 삼성생명공익재단 항-nrp1 항체 스크리닝 방법
US10919966B2 (en) 2016-08-05 2021-02-16 Y-Biologics Inc. Antibody to programmed death-ligand 1 (PD-L1) and use thereof
WO2018026249A1 (ko) 2016-08-05 2018-02-08 주식회사 와이바이오로직스 프로그램화된 세포 사멸 단백질 리간드-1 (pd-l1)에 대한 항체 및 이의 용도
BR112019002258A2 (pt) 2016-08-05 2019-05-14 Y-Biologics Inc. anticorpo que se liga a pd-1 ou fragmento de ligação ao antígeno do anticorpo, método para produzir o mesmo e composição para prevenir ou tratar câncer
KR101757346B1 (ko) 2017-03-27 2017-07-26 아주대학교산학협력단 항-emap ii 항체 및 이의 용도
KR101970327B1 (ko) 2017-04-13 2019-04-18 고려대학교 산학협력단 검출 신호의 자가 증폭 원리를 이용한 정확, 신속, 편리한 단일 단계 질병 진단 방법
KR102078292B1 (ko) 2017-05-30 2020-02-19 주식회사 종근당 신규한 항 c-Met 항체 및 이의 용도
KR102125032B1 (ko) 2017-09-08 2020-06-19 주식회사 와이바이오로직스 인간 dlk1에 대한 항체 및 이의 용도
KR102281405B1 (ko) 2017-10-20 2021-07-26 주식회사 파멥신 항-vista 항체 및 이의 용도
KR102311838B1 (ko) 2017-12-27 2021-10-14 주식회사 파멥신 항-pd-l1 항체 및 이의 용도
KR102275930B1 (ko) 2018-03-14 2021-07-12 (주)알테오젠 Folr1에 특이적으로 결합하는 항체 및 그의 용도
EP3783026A4 (de) 2018-04-18 2021-08-11 AbClon Inc. Schaltermolekül und umschaltbarer chimärer antigenrezeptor
CA3096533C (en) 2018-04-27 2023-08-29 Aimed Bio Inc. Magnetic-based biopanning method through attachment of magnetic bead to cell
KR102115300B1 (ko) 2018-06-01 2020-05-26 재단법인 목암생명과학연구소 항체 라이브러리 및 이를 이용한 항체 스크리닝 방법
KR20210043623A (ko) 2018-08-10 2021-04-21 주식회사 유틸렉스 Hla-dr에 결합하는 키메라 항원 수용체 및 car-t 세포
KR102353568B1 (ko) 2018-11-14 2022-01-20 주식회사 헬릭스미스 안정성이 향상된 항 c-Met 항체 또는 그의 항원 결합 단편
WO2020180121A1 (ko) 2019-03-06 2020-09-10 주식회사 레고켐 바이오사이언스 인간 dlk1에 대한 항체를 포함하는 항체 약물 접합체 및 이의 용도
KR102502287B1 (ko) 2020-04-17 2023-02-22 앱클론(주) 항-her2 어피바디 및 이를 스위치 분자로 이용하는 스위처블 키메라 항원 수용체
CN115667310A (zh) 2020-06-01 2023-01-31 创新生物有限公司 Cd22特异性抗体及其用途
WO2021251564A1 (ko) 2020-06-09 2021-12-16 국민대학교산학협력단 Grp94에 특이적으로 결합하는 항체 또는 그의 항원 결합 단편 및 이들의 용도
KR20220080375A (ko) 2020-12-07 2022-06-14 (주)이노베이션바이오 Cd47에 특이적인 항체 및 이의 용도
US20240141061A1 (en) 2021-01-12 2024-05-02 Sg Medical Inc Novel antibody against cd55 and use thereof
JP2024514890A (ja) 2021-04-20 2024-04-03 コリア ユニバーシティ リサーチ アンド ビジネス ファウンデーション 向上した癌細胞死滅効能を有する非対称抗体
WO2023277281A1 (ko) 2021-06-30 2023-01-05 (주)이노베이션바이오 Cd47에 특이적인 인간화 항체 및 이를 포함하는 cd47 관련 질환의 예방 또는 치료용 약학적 조성물
KR20230066257A (ko) 2021-11-05 2023-05-15 서울대학교병원 리지스틴 특이적 항체 및 이의 용도

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0305500B1 (de) * 1987-03-20 1994-11-09 Creative Biomolecules, Inc. Verfahren zur reinigung von rekombinanten polypeptiden

Also Published As

Publication number Publication date
JP2535066B2 (ja) 1996-09-18
AU1482488A (en) 1988-10-10
EP0305481A1 (de) 1989-03-08
EP0305481B1 (de) 1993-09-29
DE3884529T2 (de) 1994-04-28
JPH01503117A (ja) 1989-10-26
CA1334943C (en) 1995-03-28
AU601273B2 (en) 1990-09-06
WO1988007086A1 (en) 1988-09-22

Similar Documents

Publication Publication Date Title
DE3884529D1 (de) Leader-anteile zur produktion von rekombinanten proteinen.
DE3776783D1 (de) System zur korrektur von rechtschreibung.
PT88313A (pt) Vorrichtung zur halterung von anschlubleisten der fernmeldetechnik
DE3876453D1 (de) Methode zur kontrolle von staubbildung.
DE3885459D1 (de) Molkeproteinfraktionen.
DE3888921D1 (de) Polypeptide.
NO881658L (no) Biofunksjonelle proteiner.
NO882226D0 (no) Fibrinolytiske proteiner.
DK353788A (da) Polypeptidderivater
NO881384D0 (no) Peptider.
NO885108D0 (no) Peptider.
DE3585657D1 (de) Gegenseitige trennung von proteinen.
DE3381567D1 (de) Hestellung von rekombinanten wachstumsausloesenden faktoren.
FI885024A0 (fi) Framstaellning av koagulationshaemmande protein pp4 medelst genteknologi.
DE68910771D1 (de) Verfahren zur Herstellung von verbessertem Proteinhydrolysat.
DE3682358D1 (de) Expressionsvektoren zur verwendung in e. coli.
DE68912536D1 (de) Flüssiges Nahrungsmittel zur Proteinzuführung.
DE3884324D1 (de) Verfahren zur Herstellung von menschlichen pro-apolipoprotein-A-I-ähnlichen Proteinen.
DE3786870D1 (de) Methode zur herstellung von proteinen.
ATE95238T1 (de) Leader-anteile zur produktion von rekombinanten proteinen.
NO881942D0 (no) Fremgangsmaate for fremstilling av fremmede proteiner i streptomyceten.
DE59004279D1 (de) Verfahren zur C-terminalen Modifizierung von Proteinen.
DE3675866D1 (de) Methode zur herstellung von diphenylmethandicarbamidsaeureestern.
DE3882842D1 (de) Methode zur herstellung von cineolen.
DE3869828D1 (de) Stabilisierung von aminalane.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee